Secondary erythema nodosum occurring in a patient with inflammatory bowel disease (IBD) is an extraintestinal manifestation that requires management tailored to the underlying condition. The tender erythematous nodules typically appear on the lower extremities and reflect systemic inflammatory activity linked to the bowel disease.
The concurrent presence of inflammatory bowel disease is a key factor shaping the available treatment options. This comorbidity requires careful clinical consideration, as certain agents commonly used for erythema nodosum carry specific risks in patients with active bowel disease.
First-line management centres on symptomatic support. The initial approach includes specific physical measures directed at reducing lower-extremity edema and alleviating pain — the complete structured regimen with full clinical detail is available in the protocol below.